These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 26424648)

  • 61. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is Epstein-Barr virus transmitted sexually?
    Pagano JS
    J Infect Dis; 2007 Feb; 195(4):469-70. PubMed ID: 17230404
    [No Abstract]   [Full Text] [Related]  

  • 63. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection.
    Iwata S; Wada K; Tobita S; Gotoh K; Ito Y; Demachi-Okamura A; Shimizu N; Nishiyama Y; Kimura H
    J Gen Virol; 2010 Jan; 91(Pt 1):42-50. PubMed ID: 19793909
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2015 Jan; 32(1):12-22. PubMed ID: 25804341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis.
    Bertram G; Dreiner N; Krueger GR; Ramon A; Ablashi DV; Salahuddin SZ; Balachandram N
    In Vivo; 1991; 5(3):271-9. PubMed ID: 1654150
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Immunoglobulin M positive for cytomegalovirus and Epstein-Barr virus in a patient with infectious mononucleosis. As we interpret it?].
    Peña Irún A; González Santamaría A
    Semergen; 2012 Oct; 38(7):479. PubMed ID: 23021587
    [No Abstract]   [Full Text] [Related]  

  • 67. Burkitt lymphoma: the role of Epstein-Barr virus revisited.
    Grömminger S; Mautner J; Bornkamm GW
    Br J Haematol; 2012 Mar; 156(6):719-29. PubMed ID: 22482131
    [No Abstract]   [Full Text] [Related]  

  • 68. [Epstein-Barr virus].
    Tsurumi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():582-6. PubMed ID: 12718032
    [No Abstract]   [Full Text] [Related]  

  • 69. Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders.
    Hall LD; Eminger LA; Hesterman KS; Heymann WR
    J Am Acad Dermatol; 2015 Jan; 72(1):1-19; quiz 19-20. PubMed ID: 25497917
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute infectious mononucleosis and coincidental measles virus infection.
    Atrasheuskaya AV; Kameneva SN; Neverov AA; Ignatyev GM
    J Clin Virol; 2004 Oct; 31(2):160-4. PubMed ID: 15364274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults.
    Grotto I; Mimouni D; Huerta M; Mimouni M; Cohen D; Robin G; Pitlik S; Green MS
    Epidemiol Infect; 2003 Aug; 131(1):683-9. PubMed ID: 12948368
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modelling the dynamics of EBV transmission to inform a vaccine target product profile and future vaccination strategy.
    Goscé L; Winter JR; Taylor GS; Lewis JEA; Stagg HR
    Sci Rep; 2019 Jun; 9(1):9290. PubMed ID: 31243321
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.
    Sun C; Chen XC; Kang YF; Zeng MS
    Front Immunol; 2021; 12():677027. PubMed ID: 34168649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr virus: an important vaccine target for cancer prevention.
    Cohen JI; Fauci AS; Varmus H; Nabel GJ
    Sci Transl Med; 2011 Nov; 3(107):107fs7. PubMed ID: 22049067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute hepatitis due to infectious mononucleosis.
    Manappallil RG; Mampilly N; Josphine B
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31473633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical and laboratory characteristics of infectious mononucleosis by Epstein-Barr virus in Mexican children.
    González Saldaña N; Monroy Colín VA; Piña Ruiz G; Juárez Olguín H
    BMC Res Notes; 2012 Jul; 5():361. PubMed ID: 22818256
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Derivation and validation of clinical prediction rules for diagnosis of infectious mononucleosis: a prospective cohort study.
    de Paor M; Boland F; Cai X; Smith S; Ebell MH; Mac Donncha E; Fahey T
    BMJ Open; 2023 Feb; 13(2):e068877. PubMed ID: 36849213
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute kidney injury in symptomatic primary Epstein-Barr virus infectious mononucleosis: Systematic review.
    Moretti M; Lava SAG; Zgraggen L; Simonetti GD; Kottanattu L; Bianchetti MG; Milani GP
    J Clin Virol; 2017 Jun; 91():12-17. PubMed ID: 28410496
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role for HLA in susceptibility to infectious mononucleosis.
    Farrell PJ
    J Clin Invest; 2007 Oct; 117(10):2756-8. PubMed ID: 17909622
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New strategies and patent therapeutics in EBV-associated diseases.
    Villegas E; Santiago O; Sorlózano A; Gutierrez J
    Mini Rev Med Chem; 2010 Sep; 10(10):914-27. PubMed ID: 21034415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.